cancer
cancer on Beyond Market Intelligence: a running collection of 2 stories we have gathered and hand-picked because they are worth your time. Every post here touches on cancer in some way — the news, the analysis, the deep dives, and the occasional surprise find. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work with data. New stories are added to this page as we find them, so check back if you want to keep up with what is happening around cancer, or subscribe to the RSS feed to get them as soon as they are published. Browse the collection below, or head back to the homepage to see everything Beyond Market Intelligence is covering right now.
AI isn’t close to curing cancer. This startup says it knows what it will take.
The pursuit of AI-driven medical breakthroughs often overstates near-term possibilities. While a cure for cancer remains distant, a new startup is focusing on a fundamental truth: it’s the data, stupid. Their approach prioritizes meticulous data curation and intelligent modeling—a pragmatic strategy for unlocking insights hidden within complex biological datasets. This emphasis on foundational data practices represents a crucial shift, mirroring the innovative techniques explored in our recent piece, "Trained an diffusion model that runs on 264KB of RAM."
Public health academia to industry
Transitioning from public health academia to industry data science requires a strategic approach. Your experience with biostatistics, machine learning, and causal inference – particularly publications in journals like *JAMA Open* – establishes a strong foundation. While SQL proficiency and test-style probability questions are valuable, prioritize demonstrating practical application. Focus on building a portfolio showcasing data manipulation, model deployment, and impactful insights. Consider exploring resources like "A Marc Benioff-backed startup thinks AI can solve the AI deployment problem" for perspectives on current industry challenges and solutions.